United States · FDA National Drug Code directory
ciprofloxacin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-1648_5f4acec7-3462-49b9-962c-931fedc0f520
- Product NDC
- 50090-1648
- Form
- TABLET
- Composition / generic term
- ciprofloxacin
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20040910
- Source listing expiry
- 20261231
Source-listed ingredients
- CIPROFLOXACIN HYDROCHLORIDE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 TABLET in 1 BOTTLE (50090-1648-0) · 50090-1648-0
- 14 TABLET in 1 BOTTLE (50090-1648-1) · 50090-1648-1
- 6 TABLET in 1 BOTTLE (50090-1648-3) · 50090-1648-3
- 28 TABLET in 1 BOTTLE (50090-1648-4) · 50090-1648-4
- 10 TABLET in 1 BOTTLE (50090-1648-5) · 50090-1648-5
- 30 TABLET in 1 BOTTLE (50090-1648-7) · 50090-1648-7
- 1 TABLET in 1 BOTTLE (50090-1648-8) · 50090-1648-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →